ArticleClinical rheumatology2023

AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.

Mengyuan Duan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.